168 related articles for article (PubMed ID: 18040274)
1. Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
Shoda H; Kakugawa Y; Saito D; Kozu T; Terauchi T; Daisaki H; Hamashima C; Muramatsu Y; Moriyama N; Saito H
Br J Cancer; 2007 Dec; 97(11):1493-8. PubMed ID: 18040274
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
4. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Jpn J Radiol; 2014 May; 32(5):253-9. PubMed ID: 24562822
[TBL] [Abstract][Full Text] [Related]
5. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
6. Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
Hsieh TC; Wu YC; Ding HJ; Wang CH; Yen KY; Sun SS; Yeh JJ; Kao CH
Eur J Radiol; 2011 Dec; 80(3):e510-5. PubMed ID: 21439750
[TBL] [Abstract][Full Text] [Related]
7. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM
Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432
[TBL] [Abstract][Full Text] [Related]
8. Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
Takahashi H; Ukawa K; Ohkawa N; Kato K; Hayashi Y; Yoshimoto K; Ishiyama A; Ueki N; Kuraoka K; Tsuchida T; Yamamoto Y; Chino A; Uragami N; Fujisaki J; Igarashi M; Fujita R; Koyama M; Yamashita T
Ann Nucl Med; 2009 Jun; 23(4):391-7. PubMed ID: 19399579
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
Altini C; Niccoli Asabella A; Di Palo A; Fanelli M; Ferrari C; Moschetta M; Rubini G
Medicine (Baltimore); 2015 May; 94(20):e864. PubMed ID: 25997066
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of 2-[
Sekiguchi M; Kakugawa Y; Terauchi T; Matsumoto M; Saito H; Muramatsu Y; Saito Y; Matsuda T
J Gastroenterol; 2016 Dec; 51(12):1122-1132. PubMed ID: 27021493
[TBL] [Abstract][Full Text] [Related]
11. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Kameyama R; Yamamoto Y; Izuishi K; Takebayashi R; Hagiike M; Murota M; Kaji M; Haba R; Nishiyama Y
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344
[TBL] [Abstract][Full Text] [Related]
12. The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
Lee JE; Hong SP; Ahn DH; Jeon TJ; Kang MK; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS
Yonsei Med J; 2011 Jan; 52(1):81-8. PubMed ID: 21155039
[TBL] [Abstract][Full Text] [Related]
13. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.
Kim SK; Kang KW; Lee JS; Kim HK; Chang HJ; Choi JY; Lee JH; Ryu KW; Kim YW; Bae JM
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):148-55. PubMed ID: 16228236
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
Mochiki E; Kuwano H; Katoh H; Asao T; Oriuchi N; Endo K
World J Surg; 2004 Mar; 28(3):247-53. PubMed ID: 14961197
[TBL] [Abstract][Full Text] [Related]
15. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET.
Kamimura K; Nagamachi S; Wakamatsu H; Fujita S; Nishii R; Umemura Y; Ogita M; Komada N; Sakurai T; Inoue T; Fujimoto T; Nakajo M
Nucl Med Commun; 2009 Jun; 30(6):431-9. PubMed ID: 19352209
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
Lee JW; Lee SM; Son MW; Lee MS
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
[TBL] [Abstract][Full Text] [Related]
18. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Tian J; Chen L; Wei B; Shao M; Ding Y; Yin D; Yao S
Nucl Med Commun; 2004 Aug; 25(8):825-31. PubMed ID: 15266178
[TBL] [Abstract][Full Text] [Related]
19. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Smyth EC; Shah MA
World J Gastroenterol; 2011 Dec; 17(46):5059-74. PubMed ID: 22171140
[TBL] [Abstract][Full Text] [Related]
20. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.
Iagaru A; Quon A; Johnson D; Gambhir SS; McDougall IR
Mol Imaging Biol; 2007; 9(1):50-7. PubMed ID: 17051322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
